Cargando…

Can p53, Ki-67 and bcl-2 predict biochemical failure after radical prostatectomy?

BACKGROUND AND OBJECTIVE: To analyze p53, Ki-67 and bcl-2 expressions immunohistochemically and their predictive role in biochemical recurrence after radical prostatectomy. MATERIALS AND METHODS: Seventy one patients who had undergone radical prostatectomy between 1992 and 2001 were randomly selecte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baseskioglu, B., Akdogan, B., Baydar, D. E., Ozen, H.
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938544/ https://www.ncbi.nlm.nih.gov/pubmed/20877598 http://dx.doi.org/10.4103/0970-1591.65390

Ejemplares similares

Prognostic Significance of Lymphovascular Invasion in Clinically Localized Prostate Cancer after Radical Prostatectomy
por: Baydar, Dilek Ertoy, et al.
Publicado: (2008)

Ki-67 expression predicts biochemical recurrence after radical prostatectomy in the setting of positive surgical margins
por: Shahait, Mohammed, et al.
Publicado: (2018)

Breastfeeding and Immunohistochemical Expression of ki-67, p53 and BCL2 in Infiltrating Lobular Breast Carcinoma
por: Gonzalez-Sistal, Angel, et al.
Publicado: (2016)

Prognostic Value of Immunohistochemical Staining of p53, bcl-2, and Ki-67 in Small Cell Lung Cancer
por: Paik, Kwang Hyun, et al.
Publicado: (2006)

PCNA, Ki-67, p53, bcl-2 and Prognosis in Intraoral Squamous Cell Carcinoma of the Head and Neck
por: Nylander, Karin, et al.
Publicado: (1997)

Ki-67, p53 and BCL-2 Expressions and their Association with Clinical Histopathology of Breast Cancer among Women in Tanzania
por: Mansouri, Hidaya, et al.
Publicado: (2019)

Significance of p53 and ki-67 expression in prostate cancer
por: Verma, Renuka, et al.
Publicado: (2015)

Evaluation of P57, P53 and Ki67 Expression in Meningiomas
por: Küçükosmanoğlu, İlknur, et al.
Publicado: (2022)

How can we best manage biochemical failure after radical prostatectomy?
por: Kim, Won Tae, et al.
Publicado: (2022)

The Analysis of bcl-2 in Association with p53 and Ki-67 in Triple Negative Breast Cancer and Other Molecular Subtypes in Ghana
por: Ameh-Mensah, Charity, et al.
Publicado: (2021)

Expression of Cyclooxygenase-2, p53 and Ki-67 in Gastric Cancer
por: Joo, Young-Eun, et al.
Publicado: (2006)

Expression of p53 protein, PCNA, and Ki-67 in osteosarcomas of bone.
por: Park, H. R., et al.
Publicado: (1995)

Radiomic prediction models for the level of Ki-67 and p53 in glioma
por: Sun, Xiaojun, et al.
Publicado: (2020)

Immunoexpression of Ki67, p53 and cyclin D1 in osteosarcomas
por: Niculescu, Ştefan Adrian, et al.
Publicado: (2021)

Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort
por: Richardsen, Elin, et al.
Publicado: (2017)

Prognostic Significance of Bcl-2 and p53 Protein Expressions and Ki67 Proliferative Index in Diffuse Large B-cell Lymphoma
por: Bolat Küçükzeybek, Betül, et al.
Publicado: (2013)

Role of Bcl-2, p53, and Ki-67 expression in basal cell carcinoma and their association with aggressive and non-aggressive histological phenotypes
por: Mendez-Flores, Raúl Gerardo, et al.
Publicado: (2022)

Immunohistochemical Evaluation of p53 and Ki67 Expression in Skin Epithelial Tumors
por: Khodaeiani, Effat, et al.
Publicado: (2013)

General Clinico-Pathological Characteristics in Glioblastomas in Correlation with p53 and Ki67
por: Sipos, Tamás-Csaba, et al.
Publicado: (2023)

Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
por: Kim, Taeryung, et al.
Publicado: (2015)

The role of p53, PCNA and Ki–67 as outcome predictors in the treatment of laryngeal cancer
por: Sarafoleanu, D, et al.
Publicado: (2009)

P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients
por: Pan, Yunbao, et al.
Publicado: (2017)

Immunohistochemical expression of P53, Ki-67, and CD34 in psoriasis and psoriasiform dermatitis
por: Ramezani, Mazaher, et al.
Publicado: (2019)

Ki67 and P53 Expression in Relation to Clinicopathological Features in Phyllodes Tumour of the Breast
por: Ali, Nurul Atiah Mohd, et al.
Publicado: (2020)

Expression of p53 and Ki-67 proteins in patients with increasing severity and duration of pterygium
por: Mahesh, Mood, et al.
Publicado: (2021)

Prognostic significance of CEA, Ki67 and p53 in pseudomyxoma peritonei of appendiceal origin
por: Yan, Fengcai, et al.
Publicado: (2021)

Spontaneous expression of the gene of KI67 and P53 in cynomolgus monkeys infected with papillomavirus
por: Darusman, Huda S., et al.
Publicado: (2022)

Apoptotic and predictive factors by Bax, Caspases 3/9, Bcl-2, p53 and Ki-67 in prostate cancer after 12 Gy single-dose
por: Pisani, Carla, et al.
Publicado: (2020)

Clinicopathological and prognostic significance of Ki-67, caspase-3 and p53 expression in gastric carcinomas
por: XIAO, LI-JUN, et al.
Publicado: (2013)

Coexistence of HER2, Ki67, and p53 in Osteosarcoma: A Strong Prognostic Factor
por: Mardanpour, Keykhosro, et al.
Publicado: (2016)

Commentary: Expression of p53 and Ki-67 proteins in patients with increasing severity and duration of pterygium
por: Arora, Ritu
Publicado: (2021)

Comment on: Expression of p53 and Ki-67 proteins in patients with increasing severity and duration of pterygium
por: dos Santos Martins, Thiago Gonçalves
Publicado: (2021)

Prognostic value of the immunohistochemistry correlation of Ki-67 and p53 in squamous cell carcinomas of the larynx
por: Rodrigues, Ricardo Boose, et al.
Publicado: (2015)

Association of smoking, p53 and Ki-67 immunomarkers with bladder neoplasms in tribal region of India
por: Vaishnav, Mitsu, et al.
Publicado: (2022)

Elevated Ki-67 (MIB-1) expression as an independent predictor for unfavorable pathologic outcomes and biochemical recurrence after radical prostatectomy in patients with localized prostate cancer: A propensity score matched study
por: Byun, Seok-Soo, et al.
Publicado: (2019)

Predictive Role of p53 Protein as a Single Marker or Associated to Ki67 Antigen in Oral Carcinogenesis
por: Montebugnoli, L., et al.
Publicado: (2008)

Estimation of malignant transformation rate in cases of oral epithelial dysplasia and lichen planus using immunohistochemical expression of Ki-67, p53, BCL-2, and BAX markers
por: Shailaja, G., et al.
Publicado: (2015)

Expression of p-16, Ki-67 and p-53 markers in dysplastic and malignant lesions of the oral cavity and oropharynx
por: Yadav, Priyanka, et al.
Publicado: (2019)

Expression of p53, p63, podoplanin and Ki-67 in recurring versus non-recurring oral leukoplakia
por: Sundberg, Jonas, et al.
Publicado: (2021)

The Role of P16, P53, KI-67 and PD-L1 Immunostaining in Primary Vaginal Cancer
por: Egger, Eva K., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_50vttqk7opsmarou71vjtqhqel